What we develop

Our team supports a broad spectrum of Biologics and peptide modalities, including

    • Monoclonal antibodies and antibody fragments
    • Recombinant proteins
    • PEGylated proteins
    • Insulin analogs
    • GLP-1 analogs
    • Antibody-drug conjugates (ADC)
    • Biosimilars, generic peptides and next-generation biologics.
Our Facility & Team
  • Specialized research and development center designed to discover, design, develop, and scale biological therapeutics such as monoclonal antibodies, recombinant proteins, peptides, vaccines, gene therapies, and cell-based products.
  • Strong team with bilogics experience, has exposure to multiple development stages and understanding of regulatory expectations.
Key Highlights
  • Fully integrated R&D and pilot-scale development suites
  • Platform technologies enabling rapid, phase-appropriate development
  • Strong quality systems and regulatory support
Engineered for Success

From gene construct to clinical-ready supply, we combine deep scientific expertise with agile execution to accelerate development timelines while maintaining the highest quality and regulatory standards.

Our Commitment

We partner with you to advance your molecule with precision, speed, and confidence—delivering innovative biologics solutions aligned with your development goals.